(Q33875779)

29 July 2017

1 reference

title

Vasodilator therapy of pump failure complicating acute myocardial infarction (English)

1 reference

29 July 2017

B. M. Massie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A107378

25 April 2022

K. Chatterjee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A107378

25 April 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=107378

25 April 2022

publication date

1 January 1979

1 reference

full work available at URL

29 July 2017

https://api.elsevier.com/content/article/PII:S0025712516317151?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

https://api.elsevier.com/content/article/PII:S0025712516317151?httpAccept=text/plain

25 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

Medical Clinics of North America

25 April 2022

published in

1 reference

29 July 2017

volume

63

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

25-51

1 reference

Vascular responses after alpha adrenergic receptor blockade: I. Responses of capacitance and resistance vessels to norepinephrine in man.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Nitroglycerin ointment in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Reduction of ischemic injury by sublingual nitroglycerin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Reduction of S-T segment elevation with infusion of nitroprusside in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Acute myocardial infarction. V: Left and right ventricular haemodynamics in cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Control of myocardial oxygen consumption: physiologic and clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic effects of quantitatively varied experimental mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Combination vasodilator therapy for severe chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

The role of vasodilator therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Oral hydralazine therapy for chronic refractory heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Reversal by phenylephrine of the beneficial effects of intravenous nitroglycerin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Optimal level of filling pressure in the left side of the heart in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Influence of vasodilators upon function and metabolism of ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Intravenous nitroglycerin in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Improved left ventricular function during nitroprusside infusion in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Effects of dobutamine in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Use of Sublingual Nitroglycerin in Congestive Failure following Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Use of phentolamine in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Treatment of refractory heart failure with infusion of nitroprusside.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Reduced Systemic Vascular Resistance as Therapy for Severe Mitral Regurgitation of Valvular Origin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Effectiveness of dopamine in patients with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Use of Phentolamine in Acute Myocardial Infarction Associated with Hypertension and Left Ventricular Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Vasodilator therapy for chronic left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Left ventricular hemodynamics and function in acute myocardial infarction: studies during the acute phase, convalescence and late recovery

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Acute hemodynamic effects of dopamine in patients with shock

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Phentolamine for vasodilator treatment of severe heart-failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Arterial impedance as ventricular afterload

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Myocardial Changes Associated with Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Drug therapy. Sodium nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Contrasting effects of nitroprusside and phentolamine in experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic Evaluation of Left Ventricular Function in Shock Complicating Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Shock after acute myocardial infarction. A clinical and hemodynamic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Objective haemodynamic assessment after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Afterload as a primary determinat of ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic effects of nitroglycerin ointment in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Afterload reduction in the management of postinfarction ventricular septal defect

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Enhanced left ventricular performance with phentolamine in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Left ventricular dysfunction following acute myocardial infarction. A clinicopathologic and hemodynamic profile of shock and failure

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Shock following acute myocardial infarction. Current understanding of hemodynamic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: Prolonged effectiveness of isosorbide dinitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Heart failure complicating acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Contrasting influences of alterations in ventricular preload and afterload upon systemic hemodynamics, function, and metabolism of ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931715-1

7 January 2021

Surgical therapy for early complications of myocardial infarction

13

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

Hemodynamic profile in acute myocardial infarction

25 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

Progressive nature of myocardial injury in selected patients with cardiogenic shock

25 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

Left ventricular function in acute myocardial infarction

25 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

Protection of jeopardized ischemic myocardium by reduction of ventricular afterload

25 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

Identification of high risk subsets of acute myocardial infarction

25 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31715-1

25 November 2022

Identifiers

0 references

1 reference